제넥신, 개발 당뇨병 신약 中 임상 초읽기

글 내용 전체보기

• 

[GE Healthcare Life Science] Small-scale purification and analysis of protein samples by size exclusion chromatography (SEC)

글 내용 전체보기

Pfizer Planning to Submit Tafamidis to FDA for Rare Heart Disease

글 내용 전체보기

Xarelto Sees the Good, the Bad and the Potential for Ugly This Week

글 내용 전체보기

AbbVie’s Imbruvica and Rituxan Combo Snags FDA Approval for Rare Blood Disease

글 내용 전체보기

Esperion’s Bemopedoic Acid Treatments Hit the Mark in Two Studies

글 내용 전체보기

FDA Action Alert: Ortho Dermatologics, Tetraphase Pharma, Akcea and More

글 내용 전체보기

23andMe to Disable API Access to Outside App Developers: Report

글 내용 전체보기

ESC: Johnson & Johnson hunts for silver lining as Xarelto bombs blood clot, heart failure studies

글 내용 전체보기

AbbVie, Johnson & Johnson grab another Imbruvica nod with early OK in rare blood cancer

글 내용 전체보기

With Kymriah nod in EU, Novartis is building a plant with up to 450 jobs

글 내용 전체보기

Satan, holy water and pharma ads: Senators get fiery in push to pass DTC price tag rule

글 내용 전체보기

Hey, pharma marketers: Print is still relevant, and CMI/Compas has the receipts

글 내용 전체보기

Pfizer eyes ATTR cardiomyopathy filing for tafamidis after acing phase 3 trial

글 내용 전체보기

Allen-backed team uncovers distinctive human brain cell that may help control information flow

글 내용 전체보기

Novartis farms out rare disease drug to LifeMax Labs

글 내용 전체보기

Esperion’s cholesterol drug cuts LDL-C in phase 3

글 내용 전체보기

Substance abuse, neurological disease and more can speed up brain aging

글 내용 전체보기

Y-mAbs preps $92M IPO to push lead assets through regulatory filing

글 내용 전체보기

Better Genome Editing

글 내용 전체보기

Protection For Nerve Cells Delivered Through The Nose

글 내용 전체보기